Clinical Trial Update: Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and tolerability of P 321 ophthalmic solution in subjects with Dry Eye Disease has completed. The trial was sponsored by Par…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• P 321 Ophthalmic Solution

Snippet

Sponsor: Parion Sciences | Conditions: Dry Eye Disease | Phase 1 | Status: COMPLETED